stockrowAMNEAL PHARMACEUTICALS, INC. (AMRX) vs Kiniksa Pharmaceuticals International, plc (KNSA)
- AMNEAL PHARMACEUTICALS, INC. AMRX 19.41 −2.71%
- Kiniksa Pharmaceuticals International, plc KNSA 88.50 −7.93%
AMNEAL PHARMACEUTICALS, INC. and Kiniksa Pharmaceuticals International, plc are both Drug Manufacturers Specialty & Generic companies. AMNEAL PHARMACEUTICALS, INC. and Kiniksa Pharmaceuticals International, plc are of similar size ($6.9B and $6.8B). AMNEAL PHARMACEUTICALS, INC. trades at the lower P/E: 36.9× against 62.1×. Kiniksa Pharmaceuticals International, plc grew revenue faster over the last twelve months: 58.2% against 8.88%. Kiniksa Pharmaceuticals International, plc has the higher net margin (11.6% vs 4.17%) and the higher return on invested capital (57.7% vs 8.45%). Across the 20 metrics below, Kiniksa Pharmaceuticals International, plc leads on 14 and AMNEAL PHARMACEUTICALS, INC. on 6.
Valuation
Profitability
| Metric | AMRX | KNSA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 40.24% | 90.16% | 53.51% |
| Operating margin | 14.99% | 13.79% | 0.00% |
| Net margin | 4.17% | 11.58% | (2.45%) |
| Free cash flow margin | (1.89%) | 20.85% | 0.00% |
| Return on equity | (53,107.17%) | 17.59% | (0.80%) |
| Return on assets | 3.01% | 12.92% | (1.67%) |
| Return on invested capital | 8.45% | 57.65% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack